# A Study of LY3478006 in Healthy Participants

> **NCT04230122** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 4 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3478006 - IV
- **DRUG:** LY3478006 - SC
- **DRUG:** Placebo - IV
- **DRUG:** Placebo - SC

## Key facts

- **NCT ID:** NCT04230122
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-17
- **Primary completion:** 2020-06-04
- **Final completion:** 2020-06-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Protocol stopping criteria (safety) were met.
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04230122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04230122, "A Study of LY3478006 in Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04230122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*